McBarron Paul 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed May 22, 2013
Insider Transaction Report
Form 4
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
- Purchase
Common Stock, $0.001 par value per share
2013-05-21$3.00/sh+8,333$24,999→ 65,481 total - Purchase
Common Stock, $0.001 par value per share
2013-05-21$3.08/sh+4,615$14,214→ 70,096 total
Footnotes (1)
- [F1]The total number of shares of common stock beneficially owned by the Reporting Person has been reduced due to an inadvertent mathematical error in a prior report. Of the shares of common stock reported, 30,714 shares are represented by unvested restricted stock units.